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These guidelines will serve to advise clinicians in Japan
in the assessment of the therapeutic efficacy ofantibiot-
ics for postoperative infections. The diseases addressed
in these guidelines are listed inTable 1.The Committee
for the Prevention of Postoperative Infection has estab-
lished common guidelines concerning assessment of the
therapeutic efficacy of antibiotics for postoperative in-
fections based on an analysis of the national investiga-
tion ofpostoperative infection ofgastric cancer and rectal
cancer patients since these patients show a high inci-
dence of postoperative infection.
The Committee is in agreement that these guidelines
should be reviewed after 2 years, and that similar guide-
lines concerning postoperative infections in the fields of
obstetric/gynecologic surgery and orthopedic surgery
should also be prepared.
It is hoped that critical reports regarding these guide-
lines will be issued for the improvement of these guide-
lines.
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1. Conunon Items
1.1 Applicable diseases
Standard surgical procedures should be used
corresponding to the objective organs.
1.2 Patient selection standards
1.2.1 No patient history of adverse reactions to
the selected antibiotic.
1.2.2 A patient is suitable for assessment judged
by a physician in charge.
1.2.3 Standards for exclusion including back-
ground factors should be clearly defined.
1.3 Selection of control antibiotics
1.3.1 An antibiotic thought to be the most ef-
fective at the present time.
1.3.2 Allotment by computerized randomization
should be adopted when a double-blind
design cannot be used.
1.4 Administration of antibiotics
1.4.1 Administration of the antibiotic during
surgery is indispensable. The intravenous
administration of antibiotics for 4 days af-
ter surgery should be standard.
1.4.2 Where possible, the administration of an
antibiotic per infection should not be done
in combination with other antibiotics.
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Table 1. Diseases considered in the clinical assessment of antibiotics for postoperative
infections.
Clean operation
1. Patients who have heart valves, vascular grafts or orthopedic hardware, or synthetic
vascular prosthesis or metal replacement
2. High-risk groups
A) Patients who have more than 3 preoperative complications
B) Surgery that takes more than 2 hours
.Clean-contaminated operation
1. Abdominal surgery
A) Biliary tract surgery only for high-risk group icterus, obstruction of the bile duct,
choledocholithiasis or in patients more than 70 years old
B) Surgery of the liver or pancreas
C) Surgery of the stomach and duodenum
D) Surgery of the colon and rectum
2. Surgery of the head and neck
3. Surgery of the esophagus
4. Surgery of the obstetric and gynecological region
A) Cesarean section
B) Artificial abortion
C) Total abdominal or vaginal hysterectomy (except for malignant tumor)
5. Urologic surgery
A) Positive urine bacterial culture
6. Surgery of the respiratory system
A) Lung resection
Contaminated operation
1. Perforation of the alimentary tract
2. Appendectomy
3. Rupture of an intraabdominal parenchymatous organ
4. Trauma (more than 24 hours)
5. Open fracture
6. Broad soft tissue injury
7. Malignant tumor in the gynecologic region
1.4.3 The composition and volume ofdiluent of
a drug and the duration of administration
should be specified.
1.5 Bacterial examinations should be performed at
least on the day of surgery and the third or fourth
day after surgery.
1.6 Bacterial effects
1.6.1 The bacterial effects of the antibiotic
should be described.
1.6.2 A bacterial examination of the operative
field should be undertaken. The results of
this examination should be included in the
assessment of the antibiotic effect on the
prevention of infection.
1.6.3 Where there is a suspicion of postoperative
infection, materials for examination should
be selected.
1.7 Assessment of clinical effect
1.7. 1 The assessment of the clinical effect of an
antibiotic should be described as either the pre-
vention of infection, ineffective, or uncenain.
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1.7.2 When concomitant antibioticll are admin-
istered, the assessment should be described
as suspicion of an infection or ineffective.
1.7.3 A postoperative infection is defined as an
infection within 14 days after surgery. In-
fections developing later than 14 days af-
ter surgery should not be considered in the
assessment of the clinical effect.
1.8 The safety of an antibiotic should be assessed ac-
cording to the items described in the documented
plan.
2. Definition of Postoperative Infection
2.1 Wound infection
2.1.1 A wound infection is defined as the existence
of a purulent discharge from an operative
wound that can be observed macroscopically.
2.1.2 A wound infection also indicates the pu-
rulent discharge from drains.
2.1.3 The purulent discharge from an intestinal
fistula should be excluded from the defi-
nition of a wound infection.
2.1.4 A wound infection should be accompanied
by a general inflammatory reaction (eg, fe-
ver, leukocytosis, or elevation of C-reac-
tive protein [CRP)).
2.2 Sepsis
2.2.1 Sepsis is defined as an infection accompa-
nied by general critical symptoms of infection
and the existence of bacteria in the blood.
2.2.2 Infections from an intravenous hyperalimen-
tation (IVH) catheter should be excluded
from the definition of sepsis.
2.2.3 Endotoxemia or hypercytokinemia (eg, IL-
l, IL-2, TNF) should be treated as a posi- .
tive indication of sepsis.
2.2.4 A catheter infection that is improved by re-
moval of the catheter and demonstrates no
evidence ofbacteria in the blood should not
be included in the clinical assessment of anti-
biotic efficacy for a postoperative infection.
2.3 Postoperative intraperitoneal infection
2.3.1 The existence ofa postoperative intraperi-
toneal infection should be considered
based on the clinical symptoms of an in-
traperitoneal infection (eg, fever, muscu-
lar defense), a hemoanalysis (eg, leukocyte
analysis, CRP, erythrocyte sedimentation
rate (ESR)), the purulent discharge from
drains (if drains are present), an abdomi-
nal x-ray, ultrasonography, CT, magnetic
resonance imaging (MRI) or scintigram.
2.3.2 Infections ofthe intraperitoneal organ only
(eg, cholecystitis, hepatitis, pancreatitis,
colitis) should be excluded from the defi-
nition of an intraperitoneal infection.
2.3.3 Intraperitoneal infections should be clas-
sified as to whether the infections are due
to bacteria from indigenous bacterial flora
(eg, anastomotic insufficiency, injury to the
digestive tract, biliary tract or pancreatic
duct) or those which are not bacterial in
nature (eg, infection of dead space).
2.3.4 Intraperitoneal infection due to anasto-
motic insufficiency should be treated as a
complication, and therefore should not be
included in the clinical assessment of anti:
biotics for a postoperative infection.
2.4 Postoperative respiratory infection (postoperative
pneumonia)
2.4.1 Postoperative pneumonia is defined as a
bacterial or fungal infection of the bronchi
and lungs commonly due to tracheal in-
jury by endotracheal intubation, airway ob-
struction, atelectasis, improper swallowing,
or pulmonary edema.
2.4.2 The existence ofpostoperative pneumonia
should be considered based on clinical symp-
toms (eg, fever, increased respiration rate,
decreased breath sounds), chest x-ray, blood
gas analysis, sputum characteristics (eg, in-
crease of neutrophils or bacteria on a blood
smear, the existence of pathogenic bacteria
by culture).
2.4.3 A worsened preoperative respiratory infec-
tion after surgery also indicates postopera-
tive pneumonia.
2.4.4 The discrimination between pneumonia
and acute respiratory distress syndrome
(ARDS) without bacterial infection is dif-
ficult, but only patients whose bacteria are
confirmed by a sputum culture should be
included in the clinical assessment ofanti-
body efficacy.
2.5 Postoperative urinary infection
2.5.1 A urinary infection is defined as leukocytes
on microscopic examination or the exist-
ence of more than 103 CFU/mL ofbacte-
ria identified by urine culture. Patients who
have a urethral catheter that does not have
evidence of infection (even if the patient is
positive on the above tests) should not be
assessed for the clinical effectiveness of an
antibiotic.
2.5.2 A urinary infection includes an infection
of the urethra accompanied by miction
pain, pollakisuria, leukocytosis, and eleva-
tion ofCRP.
2.6 Postoperative biliary infection
2.6.1 Postoperative acute cholecystitis. The ex-
istence of postoperative cholecystitis
should be considered based on clinical
symptoms of the abdomen, ultrasono-
graphic findings (eg, swelling, wall thick-
ening, existence of debris), CT scans, and
other imaging modalities.
2.6.2 Postoperative cholangitis
2.6.2.1 The existence of cholangitis should
be considered based on clinical
symptoms of the abdomen, exami-
nation of liver function, biliary find-
ings (the existence of bacteria, bile
characteristics), CT, and ultrasonog-
raphy. '
2.6.2.2 Patients that have bile contaminated
with bacteria, but that are without
clinical symptoms, should be excluded
from the definition of a biliary infec-
tion.
2.6.2.3 A liver abscess also indicates a bil-
iary infection.
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2.7 Postoperative enteritis
2.7.1 Postoperative enteritis is defined as enteri-
tis with the detection of methicillin-resis-
tant Staphylococcus aureus (MRSA),
Clostridium, or other organisms from a stool
sample, accompanied by critical symptoms
of diarrhea or a paralytic ileus.
3. Standards for the Assessment ofthe Therapeutic
Efficacy ofAntibiotics for Postoperative Infections
Following Upper Abdominal Surgery
3.1 Applicable diseases
3.1.1 Total gastrectomy
3.1.2 Distal gastrectomy
These 2 operations are applicable for the clinical as-
sessment of antibiotics for the prevention of postopera-
tive infection as there is a higher than average frequency
of postoperative infection, a greater operative burden,
and a higher risk of bacterial contamination during the
operation. Operative techniques using laparoscopy are
expected to increase in frequency, and should therefore
be discussed based on detailed information in the future.
3.2 Exclusion criteria
3.2.1 A patient who has severe cardiac, hepatic
or renal disturbance.
3.2.2 A patient who received antibiotics within
7 days prior to surgery.
3.2.3 A patient whose administration of medi-
cine or examinations was not in accord-
ance with established regulations.
3.2.4 A patient unsuitable for assessment as
judged by a physician in charge.
3.3 Number of cases recommended for therapeutic
assessment
Two hundred patients treated with the antibiotic in ques-
tion and 200 control patients are the recommended
numbers of patients to adequately assess antibiotic effi-
cacy. A 10% to 30% incidence of postoperative infec-
tion was reported by this committee for the prevention
ofpostoperative infection, therefore more than 200 cases
in each treatment group is desirable.
3.4 Patient conditions and background factors
3.4.1 A patient who has more than 3 major
complications before the surgery (eg,
cerebral disturbance, obstructive pulmo-
nary disease, ischemic heart disease, dia-
betes, severe hepatic disturbance or renal
disturbances).
3.4.2 A patient whose prognostic nutritional in-
dex (Onodera's PNI) is under 40.
3.4.3 A patient with stage IV disease (based on
the Japanese classification for gastric cancer).
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3.4.4 A patient with severe pyloric stenosis.
3.4.5 A patient whose blood loss during surgery
exceeds 1000 mL.
3.4.6 A patient who has had previous surgery in-
cluding a pancreatic resection.
3.4.7 There is a high risk for postoperative in-
fection in gastric cancer patients.
3.4.8 The definition ofhigh-risk cases should be
revised as required.
In the above cases, the clinical assessment of antibiot-
ics for postoperative infection should be done more rig-
orously, particularly for the assessment of a new
antibiotic. The statistical weight of the above items is
not always equal, and therefore the use of a software
program using the "fuzzy theory" is desirable.
3.5 Selection and administration of antibiotics
3.5.1 Prophylactic antibiotics to be used for the
prevention ofpostoperative infection in gas-
tric cancer patients should include broad-
spectrum penicillins or cephems (first or
second generation) as prophylactic antibiotics.
3.5.2 The antibiotics should be given more than
once during the operation, and for up to 4
days after surgery.
3.5.2.1 For patients operated on for gastric
cancer, antibiotics for the prevention
ofpostoperative infections should be
selected from the drugs effective for
aerobic Gram-positive cocci since
these are the main bacteria in the
surgical field (except for severe py-
loric stenosis).
3.5.2.2 The administration of antibiotics
during surgery is required because
an effective blood concentration of
antibiotics in response to bacterial
contamination during surgery is
paramount. Additional administra-
tion should depend on the blood
half-life of the antibiotic used. The
duration ofantibiotic administration
after the operation should be deter-
mined in consideration of the vari-
ous patient risk factors.
3.5.2.3 The period for tissues damaged by
surgery to recover their ability to pre-
vent an infection is 72 hours.
3.5.2.4 Postoperative infections are caused
by bacteria that are not within the
spectrum of the antibiotics adminis-
tered for the prevention ofinfection.
3.5.3 The clinical assessment of the antibiotic
should be done at least within 4 days after
the operation, in consideration of the above
items.
3.6 Assessment of antibiotic efficacy during or after
an operation
3.6.1 Physical examination
3.6.1.1 Body temperature should be meas-
ured and recorded at least 4 times a
day from the day of surgery for 4
days.
3.6.1.2 The pulse rate should be measured
at least 4 times a day.
3.6.1.3 The respiration rate should be meas-
ured at least 4 times a day.
3.6.1.4 The color of the surgical wound and
all drainage sites should be examined
for redness or swelling.
3.6.1.5 Characteristics of discharge from
drains (purulent or not).
3.6.1.6 Abdominal distension and character-
istics of bowel sounds.
3.6.1.7 Breath sounds.
3.6.2 A blood biochemical examination should
be undertaken at least 2 times (on the first
day and the third or fourth day after sur-
gery). Fluctuations over time should be
monitored.
3.6.2.1 WEC count and differentialleuko-
cyte rate: if possible, the rate of staff
neutrophil should be measured.
3.6.2.2 CRP
3.6.3 Chest x-ray if respiratory complications are
suspected.
3.6.4 Bacterial examination
3.6.4.1 A bacterial examination of fluid af-
ter irrigating the intraperitoneal cav-
ity or anastomotic sites during
surgery is necessary for the assess-
ment of antibiotics for the preven-
tion of postoperative infections and
therefore should be done whenever
possible. This is essential when new
antibiotics are assessed.
3.6.4.2 A bacterial examination of the sus-
pected infection focus should be
done as soon as possible if postop-
erative infections occur. A fecal bac-
terial examination of the feces is not
necessary except when MRSA, En-
terococcus resistant to vancomycin, or
Pseudomonas is suspected.
3.6.4.3 The clinical assessment of antibiotics
on the third day or fourth day after
surgery should be comprehensive in
consideration ofthe above findings, x-
ray, ultrasonography, CT and other
imaging modalities. The use of a
"fuzzy" diagnostic system for postop-
erative infections is also recom-
mended.
3.7. Postoperative infectious disease
3.7.1 A postoperative infectious disease is defined
as an infectious disease due to a bacterium
or fungus that is increased directly or indi-
rectly by surgery or during the postoperative
management within 14 days after surgery.
3.7.1.1 Wound infection
3.7.1.2 Sepsis
3.7.1.3 Intraperitoneal infection
3.7.1.4 Respiratory infection
3.7.1. 5 Urinary infection
3.7.1.6 Biliary infection
3.7.1.7 Enteritis
3.7.2 Retrograde infections due to the long-term
indwelling ofdrains or other causes should
not be assessed because they may occur
after the prophylactic administration ofan-
tibiotics.
3.7.3 Only an IVH catheter infection that has
shown proofofbacteria in the blood should
be assessed as a postoperative retrograde
infection.
3.8 Assessment of antibiotic therapeutic efficacy
3.8.1 Effective (prevention of infection)
3.8.2 Ineffective (infection, suspicion ofinfection)
3.8.3 Indefinite
3.8.3.1 In an indefinite case, the administra-
tion of the antibiotic should be dis-
continued and reassessed at a later
time.
3.8.3.2 In cases where the antibiotic is
changed, the patient should be treated
as an ineffective case. Assessment of a
new antibiotic should be done com-
prehensively in consideration of the
reason for changing the antibiotic.
3.8.3.3 A retrograde infection due to the
long-term insertion ofa foreign body
after the administration of antibiot-
ics should not be included in the as-
sessment of effectiveness against a
postoperative infection.
3.8.3.4 Postoperative complications such as
reoperation, obvious anastomotic in-
sufficiency, or a postoperative ileus
should not be included in the assess-
ment of antibiotic efficacy because of
the difficulty in accurate assessment.
4. Standards for the AssessIne'nt ofthe Therapeutic
Efficacy ofAntibiotics for Postoperative Infections
Following Lower Abdominal Operations
4.1 Applicable diseases
4.1.1 Low anterior resection for rectal cancer
4.1.2 Excision of the rectum.
The frequency of postoperative infections
following excision of the rectum is higher
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than that for other operations. Therefore,
the clinical assessment should be done in
accordance with the surgical techniques
used. Surgical methods using laparoscopy
are expected to increase in number, and
therefore should be discussed based on
detailed information obtained in the fu-
ture.
4.2 Patient exclusion criteria
4.2.1 A patient who has severe cardiac, hepatic
or renal disturbances.
4.2.2 A patient who has received antibiotics
within 7 days prior to the surgery.
4.2.3 A patient whose administration of medi-
cine or examination was not in accordance
with recommended guidelines.
4.2.4 A patient unsuitable for the assessment as
judged by a physician in charge.
4.3 The number ofcases recommended for the assess-
ment ofa specific antibiotic is 200 treated with the
antibiotic in question and 200 controls. A 10% to
30% incidence of postoperative infection was re-
ported by this committee for the prevention of
postoperative infection, therefore more than 200
cases in each treatment group is desirable.
4.4 Preoperative colon preparation
4.4.1 Mechanical preoperative colonic prepara-
tion with cathartics should be done.
4.4.2 Preoperative colonic preparation with oral
antibiotics should be assessed by other
standards.
4.5 Patient conditions and background factors
4.5.1 High-risk cases of postoperative infection
in rectal cancer patients
4.5.1.1 A patient who has more than 3 major
complications before the operation
(eg, cerebral disturbance, obstructive
pulmonary disease, ischemic heart
disease, diabetes, severe hepatic dis-
turbance, renal disturbance).
4.5.1.2 A patient whose Onodera's PNI is
under 40.
4.5.1.3 A stage IV patient (based on the Japa-
nese classification for colon cancer).
4.5.1.4 A patient who has severe stenosis of
the colon (mechanical colonic prepa-
ration, is impossible).
4.5.1.5 A patient whose blood loss during
surgery exceeds 1000 mL.
4.5.1.6 A patient who has had previous sur-
gery including total resection of the
intrapelvic organs or other critical
operations.
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The clinical assessment of antibiotics for postoperative
infection in these patients should be done more rigor-
ously, particularly in the assessment of new antibiotics.
The definition of high-risk cases should be revised as
required. The statistical weight of the above items is
not always equal, and therefore judgment employing
computer software using the "fuzzy theory" is desir-
able.
4.6 Selection and administration of antibiotics
4.6.1 Antibiotics to be used for the prevention
of a postoperative infection in rectal can-
cer patients are those which are most ef-
fective in preventing anaerobic bacteria.
4.6.2 The antibiotics should be administered
more than once during surgery and for up
to 4 days after the operation.
4.6.3 In patients with rectal cancer, antibiotics for
the prevention of postoperative infection
should be selected from drugs effective for
aerobic Gram-negative rods (intestinal bac-
terial flora), anaerobic Gram-negative rods
(Bacteroides) or Gram-positive cocci which
easily become resistant (eg, S. aureus).
4.6.4 The administration of antibiotics during
the operation is imperative because an ef-
fective blood concentration of antibiotics
in response to bacterial contamination by
the surgery is imperative. Additional anti-
biotic administration depends on the se-
rum half-life of the antibiotic.
4.6.5 The duration of the antibiotic administra-
tion after the operation should be deter-
mined in consideration of the risk factors
of the patient.
4.6.5.1 Ittakes 72 hours for tissues damaged
by surgery to recover their ability to
prevent an infection.
4.6.5.2 Postoperative infections are caused
by bacteria that are not within the
spectrum of the antibiotics admin-
istered for the prevention of infec-
tion.
4.6.5.3 The clinical assessment ofan admin-
istered antibiotic should be done
within 4 days after the operation, in
consideration of the above items.
4.7 Assessment ofantibiotics administered during or
after surgery
4.7.1 Physical examination
4.7.1.1 Body temperature should be meas-
ured and recorded at least 4 times a
day from the day of surgery to 4 days
after operation.
4.7.1.2 The pulse rate should be measured
at least 4 times a day.
4.7.1.3 The respiration rate should be meas-
ured at least 4 times a day.
4.7.1.4 The color ofthe surgical incision and
drain insertions sites should be ex-
amined for redness and swelling.
4.7.1.5 Characteristics of drain discharge
(purulent or not).
4.7.1.6 Abdominal distension and character-
istics of bowel sounds.
4.7.1.7 Breath sounds.
4.7.2 A blood biochemical examination
should be undertaken at least twice
(on the first day and the third or
fourth day after surgery). Fluctua-
tions over time should be moni-
tored.
4.7.2.1 WBC count and differentialleuko-
cyte count: ifpossible, the rate ofstaff
neutrophil should be measured.
4.7.2.2 CRP.
4.7.3 Chest x-ray if respiratory complications are
suspected.
4.7.4 Bacterial examination
4.7.4.1 A bacterial examination of the fluid
obtained after washing the intraperi-
toneal cavity or anastomotic sites dur-
ing surgery is necessary for the
assessment of antibiotics to prevent
postoperative infections and therefore
should be done whenever possible. In
the case ofevaluating the efficacy ofa
new antibiotic, a bacterial examina-
tion should definitely be done.
4.7.4.2 A bacterial examination of the sus-
pected infection focus should be
done as soon as possible if postop-
erative infections occur. A fecal bac-
terial examination is not necessary
except when MRSA, Enterococcus
resistant to vancomycin, or Pseu-
domonas is suspected.
4.7.4.3 The clinical assessment of antibiotics
on the third day or fourth day after
surgery should be done comprehen-
sively in consideration of the above
findings, x-ray, ultrasonography, CT
and other imaging modalities.The use
of a "fuzzy" diagnostic support sys-
tem for assessment is also recom-
mended.
4.8 Postoperative infectious disease
4.8.1 A postoperative infectious disease is de-
fined as an infectious disease due to a bac-
terium or fungus that is increased either
directly or indirectly by surgery or during
postoperative management within 14 days
after the operation.
4.8.1.1 Wound infection
4.8.1.2 Sepsis
4.8.1.3 Intraperitoneal infection
4.8.1.4 Respiratory infection
4.8.1.5 Urinary infection
4.8.1. 6 Biliary infection
4.8.1.7 Enteritis
4.8.2 Retrograde infections due to the long-term
insertion of drains or other causes should
not be assessed because these may occur
after the prophylactic administration ofan-
tibiotics.
4.8.3 An IVH catheter infection that has shown
proof of bacteria in the blood should be as-
sessed as a postoperative retrograde infection.
4.9 Assessment of antibiotic therapeutic efficacy
4.9.1 Effective (prevention of infection)
4.9.2 Ineffective (infection, suspicion ofinfection)
4.9.3 Indefinite
4.9.3.1 In the case of an indefinite case, ad-
ministration of the selected antibi-
otic should be discontinued and
reassessed at a later time.
4.9.3.2 In cases where the antibiotic is
changed, the case should be treated
as an ineffective case. Assessment of
a new antibiotic should be done com-
prehensively in consideration of the
reason for changing the antibiotic.
4.9.3.3 A retrograde infection due to the
long-term insertion ofa foreign body
after the administration of antibiot-
ics should not be included in the as-
sessment of the effectiveness of an
antibiotic.
4.9.3.4 Postoperative complications such as
reoperation, obvious anastomotic in-
sufficiency, or a postoperative ileus
should not be included in the assess-
ment of the efficacy of an antibiotic
because of the difficulty in accurate
assessment.
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